Swiss pharmaceutical giant, Roche, on Tuesday, said it would invest $50 billion in the United States (U.S.) in the next five years.
The Chief Executive of the pharmaceutical giant, Thomas Schinecker, made this known on Tuesday.
Schinecker said that the commitment include new state-of-the art research and development sites as well as new and expanded manufacturing facilities in Indiana, Pennsylvania, Massachusetts and California.
He also said that the investments were expected to create more than 12,000 new jobs, including nearly 6,500 construction jobs, as well as 1,000 jobs at new and expanded facilities.
He explained that the added capacity would allow the company export more medicines from the U.S. than it imports.
”The investments underscore our long-standing commitment to research, development and manufacturing in the U.S.,” Schinecker said.
Roche is a Swiss company with a strong heritage in more than 130 countries globally.
